08:56 AM EDT, 10/08/2024 (MT Newswires) -- Health care stocks were steady pre-bell Tuesday, with The Health Care Select Sector SPDR Fund (XLV) and iShares Biotechnology ETF (IBB) inactive.

Sage Therapeutics ( SAGE ) shares were down more than 10% pre-bell after the company said that topline results from its phase 2 LIGHTWAVE study for the treatment of mild cognitive impairment or mild dementia due to Alzheimer's disease did not demonstrate a statistically significant difference in dalzanemdor-treated participants versus placebo.